Original article: cardiovascular
Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery

https://doi.org/10.1016/S0003-4975(03)00175-9Get rights and content

Abstract

Background

Cardiac dysfunction after congenital heart surgery is a major cause of morbidity and mortality. Cardiac resynchronization through multisite ventricular pacing (MSVP) improves cardiac index and ventricular function, and lowers systemic vascular resistance (SVR) in adults with heart failure and interventricular conduction delay.

Methods

The acute hemodynamic effects of MSVP after congenital heart surgery were assessed. Twenty-nine patients (aged 1 week to 17 years) with prolonged QRS interval had atrial and ventricular unipolar epicardial temporary pacing leads placed at surgery. Group 1 consisted of patients with a single ventricle (n = 14); group 2 included patients with two-ventricle anatomy (tetralogy of Fallot, ventricular septal defect) undergoing ventricular surgery (n = 10); and group 3 included patients with two-ventricle anatomy undergoing other cardiac surgery (n = 5). At a mean postoperative day 1 (range, 0 to 6), blood pressure, systemic and mixed venous oxygen saturations, electrocardiograms, and echocardiograms were obtained before and after 20 minutes of MSVP.

Results

The QRS duration decreased with MSVP in all patients (mean, 23%, p < 0.005). Systolic blood pressure improved in all patients (mean, 9.7%, p < 0.005). Cardiac index improved in 19 of 21 patients tested, with no change in 2 patients (mean, 15.1%, p = 0.0001). In 2 patients, MSVP facilitated weaning from cardiopulmonary bypass. Echocardiographic mitral or tricuspid valve inflow was not significantly different with MSVP.

Conclusions

Multisite ventricular pacing results in improved cardiac index and increased systolic blood pressure, and it can also facilitate weaning from cardiopulmonary bypass. Multisite ventricular pacing may be used as adjunct to standard postoperative treatment of cardiac dysfunction after congenital heart surgery.

Section snippets

Material and methods

The study was performed at the University of Chicago Children’s Hospital and was approved by the Institutional Review Board. Informed consent was obtained and all procedures were conducted in accordance with institutional guidelines. All patients undergoing surgery for congenital heart disease were screened for this study. We chose to perform this study in the postoperative period to assess the effects of pacing at a time when cardiac dysfunction is most pronounced. Patients were included if

Qrs complex

The QRS duration was prolonged for age in all patients before MSVP (RBBB in 11, left bundle branch block [LBBB] in 4, interventricular conduction delay in 14). Multisite ventricular capture was achieved in all patients. The mean QRS duration before pacing was 106.5 ± 22 msec and during pacing decreased in all patients to a mean of 80 ± 18 msec (23% decrease, p < 0.005; Fig 1). An example of the baseline QRS with RBBB and the QRS morphology with MSVP in a patient after surgery for tetralogy of

Comment

The major findings of this study are that MSVP in patients with bundle branch block or interventricular conduction delay results in improved CI and systolic blood pressure in the postoperative period after surgery for congenital heart disease. This improvement is associated with a decrease in the QRS duration with MSVP. The degree of hemodynamic improvement was not related to anatomic diagnosis, cardiopulmonary bypass time, cross-clamp time, baseline CI, QRS duration, or age, although the

References (17)

There are more references available in the full text version of this article.

Cited by (122)

  • Cardiac resynchronization therapy in congenital heart disease: Results from the German National Register for Congenital Heart Defects

    2018, International Journal of Cardiology
    Citation Excerpt :

    It has been suggested that a considerable proportion of CHD patients may also fulfil conventional criteria for CRT and be therefore considered potential candidates, albeit without specific data from prospective randomized trials in this population to support this approach [15]. While various case reports, small series and retrospective analysis based on single or selected specialized tertiary multicentre data have been published [16–22], the uptake and indications for this CRT for CHD in the real world remains unclear. Based on a nationwide dataset from the German National Register for Congenital Heart Defects (NR-CHD) we aimed to describe use of CRT in CHD, clarify indications and temporal trends for the use of this device therapy in the community.

View all citing articles on Scopus
View full text